USA - NASDAQ:LIEN - US8281741020 - Common Stock
The current stock price of LIEN is 10.245 USD. In the past month the price decreased by -2.67%. In the past year, price decreased by -21.38%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BX | BLACKSTONE INC | 27.39 | 178.81B | ||
| BLK | BLACKROCK INC | 23.85 | 173.20B | ||
| BN | BROOKFIELD CORP | 15.25 | 116.60B | ||
| KKR | KKR & CO INC | 23.79 | 106.61B | ||
| BAM | BROOKFIELD ASSET MGMT-A | 34.21 | 89.64B | ||
| BK | BANK OF NEW YORK MELLON CORP | 15.04 | 74.99B | ||
| ARES | ARES MANAGEMENT CORP - A | 35.07 | 49.27B | ||
| AMP | AMERIPRISE FINANCIAL INC | 13.28 | 45.16B | ||
| STT | STATE STREET CORP | 11.91 | 33.44B | ||
| OWL | BLUE OWL CAPITAL INC | 21.34 | 26.12B | ||
| NTRS | NORTHERN TRUST CORP | 14.89 | 24.44B | ||
| TROW | T ROWE PRICE GROUP INC | 11.38 | 22.90B |
Chicago Atlantic BDC, Inc. operates as a closed-end, non-diversified management investment company. The company is headquartered in New York City, New York. The company went IPO on 2022-01-31. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. The company has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The firm may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The firm is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.
CHICAGO ATLANTIC BDC INC
600 Madison Ave, Suite 1800
New York City NEW YORK US
Employees: 0
Phone: 12129054923
Chicago Atlantic BDC, Inc. operates as a closed-end, non-diversified management investment company. The company is headquartered in New York City, New York. The company went IPO on 2022-01-31. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. The company has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The firm may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The firm is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.
The current stock price of LIEN is 10.245 USD. The price increased by 0.24% in the last trading session.
CHICAGO ATLANTIC BDC INC (LIEN) has a dividend yield of 13.22%. The yearly dividend amount is currently 0.86.
LIEN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for CHICAGO ATLANTIC BDC INC (LIEN) is 9.95. This is based on the reported non-GAAP earnings per share of 1.03 and the current share price of 10.245 USD.
The Revenue of CHICAGO ATLANTIC BDC INC (LIEN) is expected to grow by 170.99% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
CHICAGO ATLANTIC BDC INC (LIEN) will report earnings on 2025-11-05, after the market close.
ChartMill assigns a technical rating of 1 / 10 to LIEN. When comparing the yearly performance of all stocks, LIEN is a bad performer in the overall market: 83.57% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to LIEN. LIEN has only an average score on both its financial health and profitability.
Over the last trailing twelve months LIEN reported a non-GAAP Earnings per Share(EPS) of 1.03. The EPS increased by 15.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 58.81% | ||
| ROA | 7.24% | ||
| ROE | 7.95% | ||
| Debt/Equity | 0.02 |
8 analysts have analysed LIEN and the average price target is 12.38 USD. This implies a price increase of 20.87% is expected in the next year compared to the current price of 10.245.
For the next year, analysts expect an EPS growth of 85.53% and a revenue growth 170.99% for LIEN